Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alaunos Therapeutics Inc TCRT

Healthcare Biotechnology
Alaunos Therapeutics, Inc. is a clinical-stage oncology-focused cell therapy company. The Company is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity... see more

Recent & Breaking News (NDAQ:TCRT)

Ziopharm Oncology Announces Strategic Reduction in Workforce and Extension in Cash Runway

GlobeNewswire September 27, 2021

Ziopharm Oncology to Participate in September Investor Conferences

GlobeNewswire September 1, 2021

Ziopharm Oncology Appoints Kevin S. Boyle, Sr., as Chief Executive Officer and Announces other Executive Promotions

GlobeNewswire August 30, 2021

Ziopharm Oncology Reports on Status of Investigational New Drug Application for Phase 1 Trial to Evaluate CD19-targeted CAR T Therapy

GlobeNewswire June 18, 2018

Ziopharm Oncology Presents Clinical Data Demonstrating Anti-tumor Immune Response of Controlled IL-12 Platform in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire June 4, 2018

Ziopharm Oncology to Present Data from Clinical Studies of Controlled IL-12 in Breast Cancer and Glioblastoma at American Society of Clinical Oncology (ASCO) Annual Meeting

GlobeNewswire May 16, 2018

New Research: Key Drivers of Growth for root9B Holdings Inc., Comfort Systems, SS&C Technologies, ZIOPHARM Oncology, L Brands, and QEP Resources — Factors of Influence, Major Initiatives and Sustained Production

GlobeNewswire May 16, 2018

22 Stocks Moving In Friday's Pre-Market Session

Benzinga.com  May 11, 2018

Ziopharm Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

GlobeNewswire May 10, 2018

Ziopharm Oncology to Announce First Quarter 2018 Financial Results, Host Conference Call May 10

GlobeNewswire May 2, 2018

New Research Coverage Highlights Great Western, Acadia Realty Trust, Interpace Diagnostics Group, Abercrombie & Fitch, United Rentals, and ZIOPHARM Oncology — Consolidated Revenues, Company Growth, and Expectations for 2018

GlobeNewswire March 9, 2018

Ziopharm Oncology Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate Update

GlobeNewswire March 1, 2018

ZIOPHARM Oncology, Inc. to Host Earnings Call

Accesswire March 1, 2018

Ziopharm Oncology Addresses Rumors and Stock Volatility, Affirms 2018 Guidance

GlobeNewswire February 6, 2018

32 Stocks Moving In Monday's Mid-Day Session

Benzinga.com  January 22, 2018

Ziopharm Oncology Provides Update on Standout Technologies during the 36th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 9, 2018

ZIOPHARM to Present at the 36th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 21, 2017

ZIOPHARM Announces Presentation of Data from T-Cell Therapy Programs at ASH Annual Meeting

GlobeNewswire December 10, 2017

ZIOPHARM Presents Positive Updated Results of Ad-RTS-hIL-12 Study in Brain Cancer at Society for Neuro-Oncology Annual Meeting

GlobeNewswire November 20, 2017

ZIOPHARM Oncology to Host Conference Call on November 20, 2017 at 10:15 a.m. ET to Discuss Updated Clinical Data Presented at the 2017 Annual Meeting of the Society for Neuro-Oncology

GlobeNewswire November 17, 2017